Caribbean experts issue WNV surveillance guidelines:
This article was originally published in Clinica
Canadian company Medical Services International is claiming a "100% accuracy" rate in an assessment of its VScan HIV I and II test kits in Haiti, in support of its campaign to extend provision of the test across the Caribbean. Medical Services believes its kit is particularly useful to the Caribbean market for being "very affordable and well suited for poorer countries", such as because it does not need to be refrigerated, does not need to be mixed, can be easily transported and provides results at the point of care.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.